Arcutis Biotherapeutics I... (ARQT)
Arcutis Biotherapeutics Max Pain By Strike
ARQT trades at $16.91, 12.7% above the near-term max pain of $15 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$97.5), signaling increased put positioning or downside protection. Key magnetic zone at 13 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Arcutis Biotherapeutics Max Pain By Expiry
Max pain for ARQT shows a downward trend from 97.5 to 2.5, indicating bearish sentiment or hedging activity. The 434% spread signals divergent expectations across timeframes. Most levels below 16.91 may cap rallies. Strong magnetic level at 13 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 15 | -1.91 (-11.27%) |
| Sep 19, 2025 | 15 | -1.91 (-11.27%) |
| Oct 17, 2025 | 2.5 | -14.41 (-85.21%) |
| Dec 19, 2025 | 12.5 | -4.41 (-26.06%) |
| Jan 16, 2026 | 12.5 | -4.41 (-26.06%) |
| Mar 20, 2026 | 12.5 | -4.41 (-26.06%) |
| Jun 18, 2026 | 97.5 | 80.59 (476.75%) |
| Jan 15, 2027 | 7.5 | -9.41 (-55.63%) |